stella
beta
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients — Stella
Home
/
Metabolic Syndrome X
/
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
View on ClinicalTrials.gov
Recruiting
Back to Metabolic Syndrome X trials
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(3 sites)
France
University Hospital Angers, Angers
Beaujon University Hospital, Clichy
Pitie Salpetriere University Hospital, Paris